|
Market Closed -
Nasdaq Stockholm
20:00:00 04/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 8.820 SEK | -1.34% |
|
+0.80% | -34.67% |
| 08-13 | Vivesto narrowed its loss in the second quarter, CEO says: we are staying on plan | FW |
| 08-13 | Vivesto AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 10.21M | - | - | - | - | - |
| 1,024B | |||||
| 663B | - | - | - | ||
| 453B | |||||
| 352B | |||||
| 304B |
- Stock Market
- Stocks
- VIVE Stock
- Charts Vivesto AB
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
